LOXL2 and melanoma: In TP-472–treated melanoma cells, several of the identified downregulated ECM proteins for example DDR1, LOXL2, CTSS, MMP9, P4HA1, CTSB, PLOD1, SPP1 have specific small-molecule inhibitors.